Brief: Exelixis Announces Settlement Of Cabometyx (Cabozantinib) Patent Litigation With Cipla Limited And Cipla USA
20/05/2024 13:29
May 20 (Reuters) - Exelixis Inc EXEL.O :
* EXELIXIS ANNOUNCES SETTLEMENT OF CABOMETYX® (CABOZANTINIB)
PATENT LITIGATION WITH CIPLA LIMITED AND CIPLA USA
* EXELIXIS-PARTIES WILL TERMINATE ALL ONGOING HATCH-WAXMAN
LITIGATION BETWEEN EXELIXIS, CIPLA REGARDING CABOMETYX PATENTS
PENDING IN U.S. DISTRICT COURT
Source text for Eikon: ID:nBw9qpb8ja
Further company coverage: EXEL.O
((Reuters.Brief@thomsonreuters.com;))